InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Yelensky Roman, Executive. Director active across 1 company, notably Gritstone bio, Inc.. Aggregated, 3 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €183k. History available since 8 March 2021. The latest transaction was disclosed on 7 January 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Roman Yelensky is an executive at Gritstone bio, Inc. While his role is not specified, he is involved in the company's leadership, which focuses on developing immunotherapeutic treatments. Roman contributes to Gritstone's mission of transforming healthcare through innovation.